                               SEQUENCE LISTING

<110> SANGAMO BIOSCIENCES, INC.
 
<120> METHODS AND COMPOSITIONS FOR GENE EDITING OF A PATHOGEN

<130> 8325-0093.40

<140> PCT/US2013/022758
<141> 2013-01-23

<150> 61/692,182
<151> 2012-08-22

<150> 61/589,734
<151> 2012-01-23

<160> 55    

<170> PatentIn version 3.5

<210> 1
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Arg Gln Asp Cys Leu Ser Leu 
1               5           


<210> 2
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Arg Asn Asp Asn Arg Lys Thr 
1               5           


<210> 3
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Thr Ser Gly Ser Leu Ser Arg 
1               5           


<210> 4
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Asp Arg Ser Asn Leu Ser Ser 
1               5           


<210> 5
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Gln Ser Ser Asp Leu Ser Arg 
1               5           


<210> 6
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Gln Ser Gly Asn Leu Ala Arg 
1               5           


<210> 7
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Arg Gln Glu His Arg Val Ala 
1               5           


<210> 8
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Asp Arg Ser Asn Leu Ser Arg 
1               5           


<210> 9
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Asp Ser Ser Ala Arg Asn Thr 
1               5           


<210> 10
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Arg Ser Asp Asn Leu Ser Val 
1               5           


<210> 11
<211> 7
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Thr Ser Gly Ser Leu Thr Arg 
1               5           


<210> 12
<211> 28
<212> DNA
<213> Plasmodium sp.

<400> 12
tggctcacgt ttaggtggag gttcttgt                                          28


<210> 13
<211> 28
<212> DNA
<213> Plasmodium sp.

<400> 13
ctgttaaggt cgacaaggga aaaaaaaa                                          28


<210> 14
<211> 28
<212> DNA
<213> Plasmodium sp.

<400> 14
ctgttaaggt cgacaaggga aaaaaaaa                                          28


<210> 15
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 15
gaaaatatta ttacaaaggg tgagg                                             25


<210> 16
<211> 29
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 16
acgaattctt agctaattcg cttgtaaga                                         29


<210> 17
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 17
ctgggcccat ggtgagcaag ggcgaggagc                                        30


<210> 18
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 18
accccgcggt taatcattct tctcatatac                                        30


<210> 19
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 19
gagtcgtatt acaattcact gg                                                22


<210> 20
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 20
cttaatcatt tgtatttggg agg                                               23


<210> 21
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 21
ctcttctact ctttcgaatt c                                                 21


<210> 22
<211> 39
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 22
ctccaccggc gccagtagta gatctggcgg cggagaggg                              39


<210> 23
<211> 34
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 23
cgcggatccg ctagcagggc cgggattctc ctcc                                   34


<210> 24
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 24
cgcggatccg ctagcgccgg gattctcctc c                                      31


<210> 25
<211> 32
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 25
cgcctaggat ggcctcctcc gaggacgtca tc                                     32


<210> 26
<211> 17
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 26
ggcgccggtg gagtggc                                                      17


<210> 27
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 27
ttcctaggat ggtgagcaag ggcg                                              24


<210> 28
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 28
ccctcgagtt acttgtacag ctcgtcc                                           27


<210> 29
<211> 49
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 29
cgaaccaacc attccgctag caccgacgtt gtggctgttg tagttgtac                   49


<210> 30
<211> 46
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 30
cagccacaac gtcggtgcta gcggaatggt tggttcgcta aactgc                      46


<210> 31
<211> 37
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 31
ccgcatatgg tgctatatca tggccgacaa gcagaag                                37


<210> 32
<211> 33
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 32
ctgacgtcga atttataaac gtttggttat tag                                    33


<210> 33
<211> 31
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 33
gggcccctat agattatttt cattgtcttc c                                      31


<210> 34
<211> 30
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 34
cgagctcaag cagaagaaca tattaatagg                                        30


<210> 35
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 35
cgagatccat ctattagggt cgac                                              24


<210> 36
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 36
ccctaataga tggatctcgt ttagg                                             25


<210> 37
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 37
ccaagttgta ctgcttctaa g                                                 21


<210> 38
<211> 23
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 38
ccaataggtt gatttatcta ttc                                               23


<210> 39
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 39
agatggctca cgtttaggtg gagg                                              24


<210> 40
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 40
gtaatgtttt atattggtag gtgg                                              24


<210> 41
<211> 24
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 41
tacaacaata ataactgctc cgag                                              24


<210> 42
<211> 39
<212> DNA
<213> Plasmodium sp.

<400> 42
ttcccttgtc gaccttaaca gatggctcac gtttaggtg                              39


<210> 43
<211> 39
<212> DNA
<213> Plasmodium sp.

<400> 43
cacctaaacg tgagccatct gttaaggtcg acaagggaa                              39


<210> 44
<211> 35
<212> DNA
<213> Plasmodium sp.

<400> 44
cttgtcgacc ttaacagatg gctcacgttt aggtg                                  35


<210> 45
<211> 35
<212> DNA
<213> Plasmodium sp.

<400> 45
cacctaaacg tgagccatct gttaaggtcg acaag                                  35


<210> 46
<211> 9
<212> PRT
<213> Unknown

<220>
<223> Description of Unknown: "LAGLIDADG" family peptide
      motif sequence

<400> 46
Leu Ala Gly Leu Ile Asp Ala Asp Gly 
1               5                   


<210> 47
<211> 19
<212> PRT
<213> Plasmodium falciparum

<400> 47
Gly Glu Gly Arg Gly Ser Leu Leu Thr Cys Gly Asp Val Glu Glu Asn 
1               5                   10                  15      


Pro Gly Pro 
            


<210> 48
<211> 56
<212> DNA
<213> Plasmodium falciparum


<220>
<221> CDS
<222> (39)..(56)

<400> 48
gtttttttta atttcttccc ttgtcgacct taacagat ggc tca cgt tta ggt gga       56
                                          Gly Ser Arg Leu Gly Gly         
                                          1               5               


<210> 49
<211> 6
<212> PRT
<213> Plasmodium falciparum

<400> 49
Gly Ser Arg Leu Gly Gly 
1               5       


<210> 50
<211> 18
<212> DNA
<213> Plasmodium falciparum


<220>
<221> CDS
<222> (1)..(18)

<400> 50
tgt gta att gaa aaa att                                                 18
Cys Val Ile Glu Lys Ile                                                   
1               5                                                         


<210> 51
<211> 6
<212> PRT
<213> Plasmodium falciparum

<400> 51
Cys Val Ile Glu Lys Ile 
1               5       


<210> 52
<211> 55
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> CDS
<222> (38)..(55)

<400> 52
gtttttttaa tttcttccct tgtcgaccct aatagat gga tct cgt tta ggt gga        55
                                         Gly Ser Arg Leu Gly Gly          
                                         1               5                


<210> 53
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 53
Gly Ser Arg Leu Gly Gly 
1               5       


<210> 54
<211> 18
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide


<220>
<221> CDS
<222> (1)..(18)

<400> 54
tgt gta att gaa ata att                                                 18
Cys Val Ile Glu Ile Ile                                                   
1               5                                                         


<210> 55
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 55
Cys Val Ile Glu Ile Ile 
1               5       


